CapsoVision Inc

CapsoVision Inc(CV)资讯与事件

$6.990

+0.195 (+2.79%)收盘时

CV 资讯

CV 事件

9/28 09:30

CapsoVision's AI Highlights Receives FDA Clearance

CapsoVision announced that AI Highlights, its AI-assisted reading tool for the CapsoCam Plus system, received clearance from the U.S. Food and Drug Administration, FDA, on September 25, 2026.

8/27 16:30

Outlook Therapeutics Appoints Kevin Lundquist as CFO

Outlook Therapeutics (OTLK) announced the appointment of Kevin Lundquist as CFO, effective September 1. Lundquist most recently served as CFO of CapsoVision (CV). In connection with Lundquist's appointment, Lawrence Kenyon will step down as CFO effective September 1. Kenyon will continue to support the company as a non-executive employee through September 30.

8/13 17:00

CapsoVision Files $250M Mixed Securities Shelf

CapsoVision files $250M mixed securities shelf

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易